Carroll P - Search Results

1

Overdiagnosis and overtreatment of prostate cancer.

Loeb S, Bjurlin MA, Nicholson J, Tammela TL, Penson DF, Carter HB, Carroll P, Etzioni R. Loeb S, et al. Among authors: carroll p. Eur Urol. 2014 Jun;65(6):1046-55. doi: 10.1016/j.eururo.2013.12.062. Epub 2014 Jan 9. Eur Urol. 2014. PMID: 24439788 Free PMC article. Review.

2

Determination of prostate volume with transrectal ultrasound for cancer screening. Part I. Comparison with prostate specific antigen assays.

Hricak H, Carroll P. Hricak H, et al. Among authors: carroll p. Invest Radiol. 1992 Sep;27(9):751-3. doi: 10.1097/00004424-199209000-00020. Invest Radiol. 1992. PMID: 1383174 No abstract available.

3

Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer.

Diaz A, Roach M 3rd, Marquez C, Coleman L, Pickett B, Wolfe JS, Carroll P, Narayan P. Diaz A, et al. Among authors: carroll p. Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):323-9. doi: 10.1016/0360-3016(94)90011-6. Int J Radiat Oncol Biol Phys. 1994. PMID: 7523343

4

The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy.

Foster LS, Jajodia P, Fournier G Jr, Shinohara K, Carroll P, Narayan P. Foster LS, et al. Among authors: carroll p. J Urol. 1993 May;149(5):1024-8. doi: 10.1016/s0022-5347(17)36287-0. J Urol. 1993. PMID: 7683341

5

Primary osteogenic sarcoma of the urinary bladder successfully treated with combination therapy.

Phan CN, Wilkinson M, Cohen MB, Dunn S, Carroll P. Phan CN, et al. Among authors: carroll p. Urology. 1994 Nov;44(5):771-4. doi: 10.1016/s0090-4295(94)80228-9. Urology. 1994. PMID: 7974956

6

Radiotherapy for high grade clinically localized adenocarcinoma of the prostate.

Roach M 3rd, Meehan S, Kroll S, Weil M, Ryu J, Small EJ, Margolis LW, Presti J, Carroll PC, Phillips TL. Roach M 3rd, et al. Among authors: carroll pc. J Urol. 1996 Nov;156(5):1719-23. J Urol. 1996. PMID: 8863578 Clinical Trial.

7

Deletion of Y-chromosome specific genes in human prostate cancer.

Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, Dahiya R. Perinchery G, et al. Among authors: carroll p. J Urol. 2000 Apr;163(4):1339-42. J Urol. 2000. PMID: 10737540

8

Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer.

Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R. Oh BR, et al. Among authors: carroll p. J Urol. 2000 May;163(5):1584-7. J Urol. 2000. PMID: 10751892

9

Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer.

Roach M 3rd, Chen A, Song J, Diaz A, Presti J Jr, Carroll P. Roach M 3rd, et al. Among authors: carroll p. Semin Urol Oncol. 2000 May;18(2):108-14. Semin Urol Oncol. 2000. PMID: 10875450

10

Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.

Carroll P, Coley C, McLeod D, Schellhammer P, Sweat G, Wasson J, Zietman A, Thompson I. Carroll P, et al. Urology. 2001 Feb;57(2):217-24. doi: 10.1016/s0090-4295(00)00993-6. Urology. 2001. PMID: 11182324 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,086 results

Search Page

Filters